There are 2789 resources available
483P - The correlation analysis between MUC16 mutation and immunotherapy predictive biomarkers in colon adenocarcinoma
Presenter: Gong Chen
Session: ePoster Display
484P - CD300c blockade promotes anti-cancer immunity and synergizes with immune checkpoint inhibitor in colon cancer
Presenter: HyeRim Shin
Session: ePoster Display
485P - A phase Ib study of cetuximab combined with fruquintinib in the previously treated RAS/BRAF wild-type metastatic colorectal cancer: The preliminary result of CEFRU study
Presenter: YONG LI
Session: ePoster Display
486P - Bioavailability and activity of oncolytic virus TG6002 after intravenous administration in patients with advanced gastrointestinal carcinomas
Presenter: Philippe A. Cassier
Session: ePoster Display
487P - Targeting PDL-1 in colon cancer using nuclear receptor 4A1 (NR41) antagonist
Presenter: Maen Abdelrahim
Session: ePoster Display
489P - MEN1611 in combination with cetuximab: Targeting PIK3CA mutations in RAS-wild-type patient-derived colorectal cancer xenografts
Presenter: Stefania Capano
Session: ePoster Display
490P - New horizons in metastatic colorectal cancer: Role of CD44 expression
Presenter: Pina Ziranu
Session: ePoster Display
491P - Lipid-engulfed macrophages at the root of gut carcinogenesis
Presenter: Elena Daveri
Session: ePoster Display
492P - Vitamin D deficiency in metastatic colorectal cancer (mCRC) worsens survival and correlates with significant peripheral inflammatory/immune cell changes
Presenter: Michela Rofei
Session: ePoster Display
493P - Impact of age on the activity of aflibercept plus FOLFIRI in metastatic colorectal cancer (mCRC): Real world data from the QoLiTrap study
Presenter: Josef Thaler
Session: ePoster Display